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INTRODUCTION  
 
Organo-catalysts are a classification of catalyst 
that are comprised of mostly carbon, hydrogen, 
oxygen, and nitrogen atoms.  Organic molecules 
used for catalysis have a long history, but recent 
interest in organo-catalysis has been turned to 
catalysts that can produce enantioselective and 
diasteroselective (optically active) products. 
Relatively recently, in the 1970s, a revolutionary 
reaction called the Hajos-Parrish-Eder-Sauer-
Wiechert reaction was carried out by using a 
naturally occurring chiral reagent, proline, as a 
catalyst to promote the synthesis of a chiral aldol 
reaction product.1  After this asymmetric reaction 
catalyzed by an organo-catalyst was reported and 
shown to be extremely enantioselective, the field  
 
 
 
 
 
 
 
 
of organo-catalysis had a huge increase in the 
amount of attention it drew.  This gain in 
asymmetric catalysis sparked more research into 
different classes of organocatalyst. During this 
gain in attention, another influential class of 
catalysts, imidazolidinone catalysts, were 
developed by David MacMillan2 by modifying 
the naturally occurring chiral phenylalanine. The 
MacMillan research group at Princeton 
University in New Jersey currently works to 
develop different organo-catalysts to aid in a wide 
range of reactions, some of which are prevalent in 
the pharmaceutical industry and also utilized in 
the total synthesis of natural products.3   
 
Dendrimers—highly branched macromolecules—present an attractive option for use as a catalytic framework because 
of their large size and their availability for functionalization. In addition, the use of organocatalysts to form 
asymmetric products has become an increasingly studied field in the pharmaceutical industry and cancer research. 
Organocatalyst terminally functionalized dendrimers present the possibility of both catalytic utility and increased 
recovery in MacMillan-type asymmetric reactions. Terminal sites of generations 2.0, 3.0, and 4.0 PAMAM 
dendrimers have been functionalized with the MacMillan group's (2S, 5S)-5-benzyl-2-tert-butyl-3-methyl-
imidazolidin-4-one catalyst. These functionalized PAMAM dendrimers were characterized by NMR and MALDI-
TOF MS analysis. The organocatalyst functionalized dendrimers show promising yield, enantioselectivity, and 
recoverability in MacMillan-type organocatalytic reactions.  

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The organo-catalysts developed by the 
MacMillan group are important for a variety of 
organic syntheses. These syntheses include high 
enantioselectivity for various commonly observed 
asymmetric organocatalytic reactions (diels-alder, 
aldol addition, and nucleophilic addition) as well 
as cascade catalysis.4 The catalysts developed for 
these reactions produce enantioselective and 
diastereoselective products, which are of interest 
to many organizations and research efforts. Most 
commonly, optically active molecules are 
extremely important in pharmaceutical 
applications where different stereoisomers can 
play very different roles in the body.5  Because of 
their wide variety of uses and the procedure used 
in synthesizing the organo-catalysts, the organo-
catalysts developed by MacMillan are relatively 
expensive to purchase.6 As of now, the catalysts 
are difficult to recover and purify for reuse, 
leading to disposal and therefore making any 
synthesis involving the catalyst expensive and 
inefficient.   
 
By modifying how MacMillan’s catalysts are 
introduced into a reaction and building multiple 
catalytic units onto a large organic framework 
instead of introducing them into a reaction as 
discrete molecules, the effective size of the 
catalytic unit increases. This increase in size leads 
to more recoverability options for the catalysts, 
and can make syntheses involving MacMillan’s 
catalysts more efficient since the catalysts can be 
recovered and reused. This project focuses on 
using dendrimers as an organic scaffold onto 
which the catalyst can be synthesized.  
 
Dendrimers are synthetic polymers that have a 
treelike structure—whose “branches” emanate 
from a single point called a core. PAMAM 
(poly(amido amine)) dendrimers are a common 
class of dendrimer used in many different 
materials science and biotechnology applications 
due to their physical properties. Dendrimers can 
be synthesized with different cores and terminal 
end groups. The synthetic route being taken in 
this project utilizes specific generations of 
PAMAM dendrimers, which have an ethylene 
diamine core, branches that contain amide 
groups, and terminate in amine groups (Figure 1).  
PAMAM dendrimers are symmetrical and adopt 
a relatively spherical shape. The terminal amine 
ends of the “branches,” or end groups, are 
relatively monodisperse over the molecule’s 
spherical surface.  These amine groups are 
reactive as nucleophiles and therefore present a 
unique opportunity as a site for functionalization 
(addition of molecules to the amine end groups) 
of the PAMAM end groups. PAMAM 
dendrimer solubility also typically mimics the 
solubility of their terminal groups, which is 
important for keeping reaction conditions 
relatively consistent when investigating the use of 
dendrimers in catalysis. PAMAM dendrimers 
can be purchased or synthesized in multiple 
generations as well—Generations 2.0, 3.0, and 
4.0 PAMAM dendrimers will be used for this 
project, which have 16, 32, and 64 amine-

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Figure 2: Varying Dendrimer Catalyst Delivery Motifs 
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= catalytic site 
Figure 1: A Generation 2.0 PAMAM Dendrimer 
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terminated end groups available for 
functionalization with the desired organo-
catalyst, respectively.7 
 
 
 
 
 
 
 
 
 
 
 
 
Dendritic catalysis has become an increasingly 
important and studied field. Three structural 
motifs that utilize the dendritic macromolecule as 
a catalyst delivery system have been investigated 
(Figure 2). In the first motif, the core of the 
dendrimer is the single catalytic unit in dendrimer 
1.8 The second, the “dendritic box” motif 2, 
utilizes pockets inside the dendrimer formed by 
the placement of its branches to capture and 
deliver the catalytic unit.9 The third motif 3, 
incorporating the largest number of catalytic 
units, covalently binds catalytic units to the 
terminal ends of the dendrimer.10-14 Using the 
motif in 3 and covalently binding the catalyst to 
the amine end groups of the PAMAM dendrimer  
framework is ideal for our method of dendritic 
catalysis because it allows separation of the 
catalyst with any method of separation that could 
be utilized with dendrimers or other similar 
macromolecules. 
 
 
 
 
 
 
 
 
 
 
PAMAM dendrimers were chosen in particular 
for this work due to their properties for an ideal 
platform for catalysis. Their spherical shape, 
solubility properties, organic structure, and 
monodisperse end groups make them attractive as 
a framework for organocatalysis. The spherical 
shape and monodisperse end groups of a 
PAMAM dendrimer are an optimal way to 
deliver a catalyst to a system because the catalytic 
site is on the surface of the molecule, leading to 
ready accessibility to reagents for catalysis. 
Solubility properties of PAMAM dendrimers 
typically mimic those of the end groups, 
especially in higher generations. This provides 
the opportunity to keep solvent reaction 
conditions consistent between dendrimer-bound 
catalysis and catalysis using free, unbound 
catalysts. The organic structure of the PAMAM 
catalysts provides the option of covalently binding 
molecules to the terminal end-groups.  
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Figure 3: Dendrimer generations 2.0-4.0 Functionalized with 
MacMillan’s (2S, 5S)-5-(1-benzyl-1H-indol-3-yl)—tert-butyl-
3-methyl-imidazolidin-4-one catalyst.  


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By exploiting the reactive amino end groups, 
functionalizing the PAMAM dendrimers with 
MacMillan's (2S, 5S)-5-(1-benzyl-1H-indol-3-
yl)-2-tert-butyl-3-methyl-imidazolidin-4-one  
catalyst (therefore increasing the effective size of 
the catalytic delivery framework) provides a route 
for catalyst purification. The size of the organo-
catalyst functionalized dendrimers theoretically 
introduce the opportunity for recovery and reuse 
by filtration, dialysis, or size exclusion 
chromatography, which makes the MacMillan 
group’s procedures more economically feasible 
and environmentally friendly. Recovery and reuse 
of this catalyst could impact the fields of green 
chemistry as well as the pharmaceutical industry.  
 
DISCUSSION  
 
Catalyst Functionalization of Dendrimers 
A set of three PAMAM dendrimers 4-6 were 
functionalized with a MacMillan-type 
imidazolidinone catalyst known to perform 
enantioselective catalysis (Figure 3). Although 
the dendrimer bound catalysts illustrated only 
show one catalytic unit per dendrimer, these 
schematics symbolize fully mono-functionalized 
dendrimers with the number of end groups 
functionalized respective to their generation. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Dendrimers 4-6 were functionalized using an 
approach adapted from a related 
functionalization by Koskinen and coworkers15   in 
order to develop the synthetic scheme to produce 
the desired imidazolidinone catalyst (Scheme 1). 
Coupling of N- fluorenylmethyloxycarbonyl 
(fmoc) protected L-phenylalanine with the free 
amine surface of each generation of PAMAM 
dendrimer was completed under 
hydroxybenzotriazole and diisopropyl-
carbodiimide conditions. Deprotection of the 
resulting material 7 was accomplished with 
piperidine to reveal the phenylalanine-
functionalized dendrimer 8. Treating the 
dendrimer with pivaldehyde in 
dimethylformamide resulted in the mono-
functionalized dendrimers 4-6.  
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Scheme 1 
 	 
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The method that was adapted for the PAMAM 
dendrimer functionalization in Scheme 1 was not 
initially intended or optimized for varying 
generations of PAMAM dendrimer. Work on 
this project also included optimization of 
reagents, reaction conditions, and purification 
methods for the synthesis in Scheme 1.  Reagent 
amounts were scaled appropriately for the 
number of amino end groups on the dendrimer, 
instead of a linear molar ratio. Reaction times 
were increased in order to allow reagents to 
navigate through the dendritic framework and 
react with terminal amino end groups. The pH of 
reactions were adjusted to be compatible with 
PAMAM dendrimer structure (pH 4-9). The 
first two steps in Scheme 1 were found to be able 
to be completed in dimethylsulfoxide (DMSO) 
instead of dimethylformamide (DMF) in order to 
minimize hazardous chemical exposure and wear 
on lab instruments.16,17  Pi-stacking of excess 
fmoc-phenyalanine with dendrimer-
functionalized fmoc-phenylalanine inside the 
dendritic framework required that steps one and 
two in Scheme 1 were completed as a one-pot 
synthesis in order to drive all fmoc from the 
dendritic framework at once with an excess of 
piperidine in the deprotection step. This one-pot 
synthesis streamlined separation of fmoc from the 
phenylalanine-functionalized dendrimer 8. 
Completing steps one and two in Scheme 1 as a 
one-pot synthesis also maximized recovery of 8 
due to no loss of 7 in an unnecessary and time 
consuming purification step.  
 
Functionalized dendrimer 8, as well as 
functionalized dendrimers 4,5,6 were purified via 
dialysis in DMSO.  Since DMSO was found to 
be trapped inside of the dendritic material, an 
additional step to drive solvent from the material 
was needed. When DMSO from dialysis is being 
removed via lyophilization, millipore water is 
added to the mixture to drive DMSO from the 
internal dendritic framework as well as creating 
diluted solution of DMSO and water that aides 
in the removal of solvent from the dendrimer 
material, as water has a higher vapor pressure 
(17.54 mmHg)18 than DMSO (0.42 mmHg)19. 
This results in the DMSO almost completely 
leaving the internal dendritic framework by 
lyophilization to provide more accurate yields by 
weight as well as not interfering with any 
characterization methods. Additionally, in the 
process of developing the parameters shown in 
Scheme 1, it was found that cyclization of the 
catalyst in step 3 of Scheme 1 was sometimes not 
completely successful due to excess solvent, not 
enough reagent, or not long enough of a reaction 
time. In these cases, it was found that if the 
material was re-submitted to the reaction 
conditions in step 3 of Scheme 1, additional 

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Scheme 2 
Scheme 3 
cyclization would occur, further functionalizing 
the dendrimer with the desired catalyst. During 
the course of this work the parameters for step 3 
of Scheme 1, including amounts of solvent, 
reagent, and reaction time, were optimized. The 
methods used to cyclize the catalyst are now 
efficient enough to produce quantitative yields of 
dendrimer functionalized with cyclized catalyst in 
one ring-closing reaction. For the purification of 
the resultant fully functionalized dendrimer-
bound catalyst, DMF must be evaporated via 
lyophilization before submitting the material to 
dialysis, since DMF will degrade the dialysis 
tubing (made of regenerated cellulose) that is 
compatible with DMSO.  
 
The resultant new dendrimers 4-6 were 
characterized using 1H NMR and 13C NMR 
spectroscopy techniques as well as matrix assisted 
laser desorption ionization time-of-flight 
(MALDI-TOF) mass spectrometry. Multiple 
matrices used for MALDI-TOF-MS were 
investigated in order to optimize dendrimer 
characterization, including trans-3-indoleacrylic 
acid (IAA) and 2,5-dihydroxybenzoic acid 
(DHB). Optimal MALDI-TOF-MS results 
were obtained using DHB as a matrix.  
 
Catalytic Activity of Catalyst-Functionalized 
Dendrimers 
Functionalized PAMAM dendrimers 4-6 were 
evaluated for their ability to promote 
enantioselective catalysis using selected reactions 
catalyzed by the MacMillan-type 
imidazolidinone catalyst that was built onto the 
dendritic framework (Schemes 2, 3).20,21 
 
 
 
 
 
 
 
 
 
 
The reactions in Scheme 2 and 3 were chosen to 
demonstrate the catalytic utility of the dendrimer 
because they were within the range of what is 
compatible with the framework of a PAMAM 
dendrimer. The reactions in Schemes 2 and 3 
were run at room temperature. This is 
advantageous as low temperatures cannot be 
supported for more than 8 hours in our lab, and 
temperatures over 30°C can degrade the 
framework of the dendrimer. The reactions 
chosen were also performed in a pH range that 
was adequate for the dendrimer framework, as the 
framework can also degrade over pH of 9, and at 
pHs lower than 3, the amine groups inside the 
dendrimer are ionized and the dendrimer can 
precipitate out of solution as a salt.  Since these 
are screening reactions, the reactions in Scheme 2 
and 3 were also chosen due to their readily 
available or relatively inexpensive reagents.  
 
In order to gather sufficient evidence to support 
our dendrimer-bound catalyst’s utility, reactions 
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shown in Scheme 2 and 3 were run under only 
acidic conditions (no catalyst), the original 
conditions published (free catalyst), and with the 
dendrimer-bound catalysts 4, 5, 6. The time until 
reaction completion, percent yield, optical 
activity, and catalyst recovery were compared to 
values reported by the MacMillan group.  
Enantiomeric excess was determined via 
polarimetry in chloroform.  
 
Solvent Studies and Other Notable Observations 
Although dendrimer solubility generally mimics 
the solubility of their end groups, lower 
generations of PAMAM dendrimers can exhibit 
different solubility properties in certain organic 
solvents because of their less spherical shape 
(compared to higher generations) and exposed 
internal structure. A series of control reactions for 
the aniline addition reaction in different solvents 
were used in order to determine catalyst 
functionality in differing solvent environments in 
order to broaden possible reaction conditions.  
 
During these solvent studies, multiple things 
were discovered about the practical process of the 
procedures in Scheme 2 and 3 with dendrimer-
bound material. In the reaction shown in Scheme 
3, an amber vial (preferably subsequently covered 
in tinfoil) must be used in order to prevent light 
degradation of the 1-phenylpyrrolidine starting 
material. In the reaction shown in Scheme 3, 
there is also a cooling step to -10°C. When 
running the reaction in Scheme 3 with DMSO as 
a solvent, the cooling step cannot be employed 
because of the freezing point of DMSO at 19°C.22 
Though the reaction cannot be cooled, it was 
found that it had no noticeable effect on the yield 
or enantioselectivity of the reaction.  If the solvent 
used in the nucleophilic addition reaction is 
DCM, parafilm should not be used in order to 
prevent DCM from leeching the hard-to-
separate parafilm into the reaction mixture.  
 
Since the nucleophilic addition reaction in 
Scheme 3 is run in acidic conditions, there is also 
a reaction acidifying step. The amount of acid in 
the original reaction is the amount needed to 
acidify all of the catalyst material. However, in a 
system using the dendrimer-bound catalyst, some 
of the internal framework of the dendrimer is 
protonated before the catalytic groups on the 
surface of the dendrimer. It was found that the 
amount of acid needed to be increased in a 
dendrimer-bound catalyst system in order to 
protonate the catalytic groups and run the 
reaction successfully. However, because of the 
chance of the dendrimer framework being 
completely protonated and precipitating out of 
solution, the reaction must be kept above a pH of 
3.  
 
Dialysis was used to purify the dendrimer 
material from the reaction mixture, since the 
dendrimer material should stay in the dialysis 
tubing as the reaction mixture diffuses outside of 
the dialysis tubing. Dialysis in DMSO was 
initially tried, but the lyophilization procedure 
from evaporating DMSO was time consuming. 
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Dialysis in DCM was also attempted, but it was 
found that DCM in large volumes degraded the 
dialysis tubing and leeched cellulose into the 
reaction mixture. Removing the cellulose from 
the reaction mixture added an extra 
chromatography purification step (in addition to 
the chromatographic method to purify product 
from reagents), so DCM was discarded as a 
potential solvent for dialysis and the use of 
DMSO had evidence of being more efficient than 
DCM in these conditions.  
 
Purification of the desired products from the 
reactants was performed via silica gel 
chromatography. It was found that 
chromatography using a Chromatotron (a 
centrifugal thin-layer silica gel purification 
system)23 with a hand-held UV lamp was more 
efficient, used less solvent, and provided better 
separation and yields than classic flash or gravity 
chromatography with silica gel.  
 
RESULTS 
 
Three generations of dendrimer-bound (2S, 5S)-
5-benzyl-2-tert-butyl-3-methylimidazolidin-4-
one were successfully synthesized with good 
functionalization yield. Phenylalanine 
functionalization was completed in near 
quantitiative yield (Table 1, Steps 1 and 2 to 
produce 8 in Scheme 1). Cyclization into the 
complete catalyst (Step 3 to produce 4,5,6 in 
Scheme 1) was completed in high yield when 
characterized by NMR, but MALDI-TOF-MS 
data shows a lower yield of cyclization (Table 1).  
 
Table 1: Percent functionalization for 8 and 4,5,6 by both NMR 
and MALDI-TOF-MS 
 
GENERATION PAMAM 8  PAMAM 4,5,6 
 MALDI NMR MALDI NMR 
G(2.0) Quant. Quant. 26% 86% 
G(3.0) 91% Quant. 32% 90% 
G(4.0) 97% Quant.  26% 93% 
 
Because of the internal consistency of percent 
functionalization found via both MALDI-TOF-
MS and NMR spectroscopy, respectively, and 
due to the nature of the high-powered laser used 
in MALDI-TOF-MS, it is theorized that the 
laser fragments the fragile fully cyclized catalyst 
functionalized dendrimer. Further investigation 
is currently being conducted to determine 
another method of characterization to determine 
the mass of the catalyst functionalized 
dendrimers to confirm this theory.  
 
 Two reactions   published by MacMillan using 
free (2S, 5S)-5-benzyl-2-tert-butyl-3-
methylimidazolidin-4-one were investigated by 
substituting free catalyst with dendrimer-bound 
catalyst, and evidence shows that the dendrimer-
bound catalyst both catalyzes these reactions and 
produces the same rotation in chirality in the 
desired product. (Table 2).  
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Table 2: Comparison of Free Catalyst and Dendrimer-Bound 
Catalyst Activity  
  
             FREE CATALYST  
DENDRIMER-
BOUND CATALYST  
ANILINE 
ADDITION 
(DCM) 
Yield 89% 32% 
 Optical 
Rotation 
-2.77°    -0.4°  
(observed rotation) 
 
DIELS ALDER 
(ACN/WATER) 
Yield 4% 24% 
 Optical 
Rotation 
-536° -460° 
 
 
Since both control and on-dendrimer catalyzed 
reactions ran to completion via NMR 
monitoring, the discrepancy in percent yield is 
attributed to purification error. The optical 
rotation for all products produced by dendrimer-
bound catalyst is concurrent with the chirality 
observed with free catalyst, which is promising 
for future work because the optical rotation 
provides evidence the dendrimer-bound catalyst 
works with similar enantioselectivity to the free 
catalyst. 
 
 Attempts to recover the dendrimer-bound 
catalyst were initially successful but are currently 
being optimized.  Purification of the dendrimer-
bound catalyst by filtration was initially seemed 
promising because of limited dendrimer solubility 
in acetonitrile and water, but NMR analysis 
showed high levels of starting reagents trapped 
inside the dendrimer framework after washing of 
the filtrate. Dialysis against DMSO using 
regenerated cellulose dialysis tubing with a 
MWCO of 3500 kDa proved a more efficient 
way to purify dendrimer-bound catalyst. (Table 
3).  
 
 Table 3: Recovery of dendrimer-bound catalyst using dialysis  
 
TRIAL  NUMBER   GENERATION PERCENT 
RECOVERY 
1 G (3.0) 14  
2 G (3.0) 6  
3 G (3.0) 43  
4 G (2.0) 28  
 
There has not yet been any evidence of a 
correlation between dendrimer generation used 
and yield or recovery.  
 
CONCLUSIONS 
 
Three generations (2.0, 3.0, and 4.0) of 
dendrimer-bound (2S, 5S)-5-benzyl-2-tert-
butyl-3-methylimidazolidin-4-one catalyst have 
been successfully synthesized. The dendrimer-
bound catalysts demonstrate similar yield and 
optical activity to free (2S, 5S)-5-benzyl-2-tert-
butyl-3-methylimidazolidin-4-one catalyst as 
reported by MacMillan. The dendrimer-bound 
catalysts also demonstrate higher potential for 
recovery of catalyst than free catalyst. Recovery 
methods are currently being optimized, most 
promisingly through dialysis techniques. The 
efficiency of the dendrimer-bound catalyst after a 
number of uses and recoveries is also being 
investigated. Future work will include optimizing 
catalytic conditions and developing orthogonal 
catalysts for multistep or cascade catalysis, as well 
as attempting different catalytic delivery and 
recovery methods through the use of linking the 

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dendrimer-bound catalyst to a gold surface for 
solid-support catalysis.  
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EXPERIMENTALS 
 
Generation 2.0 PAMAM-based nitrogen-
linked phenylalanine dendrimer (8): 
An aqueous solution of amine-terminated 
Starburst PAMAM dendrimer (Generation 2.0, 
12.57% (w/w)) was lyophilized. The resulting 
residue (124.8 mg, 0.0383 mmol, 1 eq) was 
dissolved in DMSO ( 1.0 mL). In a separate 
scintillation vial, a solution of 9-
fluorenylmethoxycarbonyl-L-phenylalanine 
(0.9442 g, 2.43 mmol, 64 eq) and 
hydroxybenzotriazole (0.3375 g, 2.49 mmol, 64 
eq) in DMSO (4.0 mL) was added to a solution 
of N,N'-diisopropylcarboimide (382 uL, 2.43 
mmol, 64 eq) in DMSO (0.25 mL) and allowed 
to stir for five minutes. The two solutions were 
combined and stirred (2.5 h) to form 7. This 
product was dialysed against DMSO (MW cutoff 
1 kDa). The solution was lyophilized to give 7. 
This product was used without further 
purification.  
 
Resulting crude product 7 was deprotected in a 
20% (v/v) solution of piperidine/ DMSO by 
dissolving in DMSO (7.0 mL) and adding 
piperidine (1.75 mL). After 110 minutes of 
stirring, the reaction mixture was dialysed against 
DMSO (MW cutoff 1 kDa). The solution was 
lyophilized using water to drive out DMSO to 
give title compound (8) as a fluffy, white solid 
(136.6 mg). 1H NMR (500MHz, CD3OD)  
(ppm) 2.31 (m, 61H, PAMAM-x), 2.54 (m, 
28H, PAMAM-x), 2.76 (m, 61H, PAMAM-x),  
 
 
2.97, 3.01 (m, 16H, PhCH2CH), 3.21 (m, 96H, 
PAMAM-x), 3.50 (m, 16H, PhCH2CH), 7.20, 
7.28 (m, 80H, Ph) ppm; 13C NMR (500MHz, 
CD3OD)  34.7, 38.6, 39.9, 40.4, 42.5, 51.1, 
53.4, 57.9, 127.9, 129.7, 130.5, 139.0, 175.1, 
176.9 ppm; MALDI-TOF-MS (pos) 5628.  
 
Generation 2.0 PAMAM-based nitrogen-
linked (2S,5S)-(-)-2-tert-butyl-3-methyl-5-
benzyl-4-imidazolidinone dendrimer (4):  
Phenylalanine functionalized G (2.0) PAMAM 
(8) (126.6 mg, 0.2256 mmol, 1 eq) was dissolved 
in dimethylformamide (1.5 mL) and pivaldehyde 
was added (490 uL, 4.51 mmol, 200 eq). N, N'-
diisopropylethylamine was added until the 
reaction mixture reached a pH of 9. The reaction 
mixture was stirred for approximately 40 hours. 
This product was lyophilized to remove DMF, 
re-dissolved in DMSO and dialysed against 
DMSO (MW cutoff 1 kDa). The solution was 
lyophilized using water to drive out DMSO to 
give title compound 4 as a pale yellow glassy solid 
(89.2 mg). []D= -131.5;  1H NMR (500MHz, 
CD3OD)  0.85 (s, 123H, tert-butyl) 2.31 (m, 
60H, PAMAM-x) 2.52 (m, 28H, PAMAM-x), 
2.74 (m, 61H, PAMAM-x) 3.21 (m, 96H, 
PAMAM-x) 3.65, 3.69 (dd, 16H, PhCH2CH) 
6.88, 7.06, 7.21 (m, 80H, Ph) ppm; 13C NMR 
(500MHz, CD3OD)  (ppm) 27.2, 34.8, 37.3, 
38.7, 40.1, 40.5, 41.8, 42.6, 51.2, 53.6, 58.0, 76.1, 
127.7, 129.4, 129.7, 130.6, 131.2, 138.9, 174.6, 


174.7, 175.1, 175.5, 176.5, 177.0 ppm; MALDI-
TOF-MS (pos) 6118. 
 
Generation 3.0 PAMAM-based nitrogen-
linked phenylalanine dendrimer (8): 
An aqueous solution of amine-terminated 
Starburst PAMAM dendrimer (Generation 3.0, 
7.01% (w/w)) was lyophilized. The resulting 
residue (116.8 mg, 0.0169 mmol, 1 eq) was 
dissolved in DMSO ( 2.0 mL). In a separate 
scintillation vial, a solution of 9-
fluorenylmethoxycarbonyl-L-phenylalanine 
(0.8398 g, 2.17 mmol, 128 eq) and 
hydroxybenzotriazole (0.2950 g, 2.18 mmol, 128 
eq) in DMSO (3.0 mL) was added to a solution 
of N,N'-diisopropylcarboimide (340 uL, 2.18 
mmol, 128 eq) in DMSO (1.0 mL) and allowed 
to stir for five minutes. The two solutions were 
combined and stirred (2.5 h) to form 7. This 
product was dialysed against DMSO (MW cutoff 
3.5 kDa). The solution was lyophilized to give 7. 
This product was used without further 
purification.  
 
Resulting crude product 7 was deprotected in a 
20% (v/v) solution of piperidine/ DMSO by 
dissolving in DMSO (5.5 mL) and adding 
piperidine (1.4 mL). After 60 minutes of stirring, 
the reaction mixture was dialysed against DMSO 
(MW cutoff 3.5 kDa). The solution was 
lyophilized using water to drive out DMSO to 
give title compound 8 as a fluffy, white solid 
(122.2 mg). 1H NMR (300MHz, CD3OD)  
(ppm) 2.33 (m, 124H, PAMAM-x), 2.56 (m, 
57H, PAMAM-x), 2.77 (m, 119H, PAMAM-
x), 2.96 (m, 61H, PhCH2CH), 3.21 (m, 182H, 
PAMAM-x), 3.51 (m, 32H, PhCH2CH), 7.21, 
7.28 (m, 169H, Ph); 13C NMR (500MHz, 
CD3OD)  (ppm) 34.8, 28.6, 40.0, 40.4, 42.5, 
128.0, 129.6, 130.6, 139.1, 174.6, 175.1, 176.9 
ppm; MALDI-TOF-MS (pos) 10606.  
 
Generation 3.0 PAMAM-based nitrogen-
linked (2S,5S)-(-)-2-tert-butyl-3-methyl-5-
benzyl-4-imidazolidinone dendrimer (5):   
Phenylalanine functionalized G (3.0) PAMAM 8 
(122.2 mg, 0.012 mmol, 1 eq) was dissolved in 
dimethylformamide (2.0 mL) and pivaldehyde 
was added (228 uL, 2.05 mmol, 200 eq). N, N'-
diisopropylethylamine was added until the pH of 
the reaction mixture reached 9. The reaction 
mixture was stirred for approximately 40 hours. 
This product was lyophilized to remove DMF, 
re-dissolved in DMSO and dialysed against 
DMSO (MW cutoff 3.5 kDa). The solution was 
lyophilized using water to drive out DMSO to 
give title compound 5 as a pale yellow glassy solid 
(126.1 mg). 1H NMR (500MHz, CD3OD)  
0.89 (s, 252H, tert-butyl), 2.35 (m, 120H, 
PAMAM-x), 2.57 (m, 56H, PAMAM-x) 2.78 
(m, 121H, PAMAM-x), 3.25 (m, 185H, 
PAMAM-x), 3.71, 3.74 (dd, 31H, PhCH2CH), 
6.93, 7.09, 7.24 (m, 163H, Ph) ppm; 13C NMR 
(500MHz, CD3OD)  ppm 25.1, 25.8, 33.4, 
35.9, 37.3, 38.7, 39.1, 40.4, 41.2, 49.8, 52.2, 
56.6, 74.6, 126.3, 128.0, 128.3, 129.2, 129.8, 
137.5, 173.7, 174.1, 175.1; (500MHz, 


CD3OD)  ppm; MALDI-TOF-MS (pos) 
11372. 
 
Generation 4.0 PAMAM-based nitrogen-
linked phenylalanine dendrimer (8): 
An aqueous solution of amine-terminated 
Starburst PAMAM dendrimer (Generation 4.0, 
13.12% (w/w)) was lyophilized. The resulting 
residue (123.7 mg, 0.0087 mmol, 1 eq) was 
dissolved in DMSO ( 2.0 mL). In a separate 
scintillation vial, a solution of 9-
fluorenylmethoxycarbonyl-L-phenylalanine 
(0.8622 g, 2.23 mmol, 256 eq) and 
hydroxybenzotriazole (0.3067 g, 2.27 mmol, 256 
eq) in DMSO (4.0 mL) was added to a solution 
of N,N'-diisopropylcarboimide (346 uL, 2.22 
mmol, 256 eq) in DMSO (0.5 mL) and allowed 
to stir for five minutes. The two solutions were 
combined and stirred (2.5 h) to form 7. This 
product was dialysed against DMSO (MW cutoff 
3.5 kDa). The solution was lyophilized to give 7. 
This product was used without further 
purification.  
 
Resulting crude product 7 was deprotected in a 
20% (v/v) solution of piperidine/ DMSO by 
dissolving in DMSO (7.0 mL) and adding 
piperidine (1.75 mL). After 90 minutes of 
stirring, the reaction mixture was dialysed against 
DMSO (MW cutoff 3.5 kDa). The solution was 
lyophilized using water to drive out DMSO to 
give title compound 8 as a fluffy, white solid 
(161.4 mg). 1H NMR (500MHz, CD3OD)  
(ppm) 2.29 (m, 240H, PAMAM-x), 2.52 (m, 
112H, PAMAM-x), 2.73 (m, 243H, PAMAM-
x), 2.98 (m, 63H, PhCH2CH), 3.21 (m, 368H, 
PAMAM-x), 3.51 (64H, m, PhCH2CH), 
7.19,7.25 (m, 319H, Ph) ppm; 13C NMR 
(500MHz, CD3OD)  (ppm) 34.8, 38.7, 40.0, 
40.5, 42.6, 51.3, 53.6, 57.8, 127.9, 129.6, 130.6, 
139.0, 175.2, 176.8 ppm; MALDI-TOF-MS 
(pos) 21164.  
 
Generation 4.0 PAMAM-based nitrogen-
linked (2S,5S)-(-)-2-tert-butyl-3-methyl-5-
benzyl-4-imidazolidinone dendrimer (6):  
Phenylalanine functionalized G (4.0) PAMAM 8 
(151.8 mg, 0.0066 mmol, 1 eq) was dissolved in 
dimethylformamide (1.5 mL) and pivaldehyde 
was added (143 uL, 1.32 mmol, 200 eq). N, N'-
diisopropylethylamine was added until the pH of 
the reaction mixture reached 9. The reaction 
mixture was stirred for approximately 40 hours. 
This product was lyophilized to remove DMF, 
re-dissolved in DMSO and dialysed against 
DMSO (MW cutoff 3.5 kDa). The solution was 
lyophilized using water to drive out DMSO to 
give title compound 6 as a pale yellow glassy solid 
(99.3 mg). []D= -47.4; 1H NMR (500MHz, 
CD3OD)  0.89 (s, 521H, tert-butyl), 2.35 (m, 
239H, PAMAM-x), 2.56 (m, 119H, PAMAM-
x), 2.78 (m, 239H, PAMAM-x), 3.25 (m, 366H, 
PAMAM-x), 3.71 (dd, 62, PhCH2CH), 6.92, 
7.08, 7.22 (m, 320H, Ph) ppm; 13C NMR 
(500MHz, CD3OD)  25.4, 26.4, 27.4, 35.0, 
37.4, 40.2, 40.3, 40.7, 42.0, 51.3, 53.8, 58.1, 76.2, 
127.9, 129.6, 129.9, 131.4, 139.0, 139.3, 174.7, 


174.8, 175.2, 176.6, 177.0 ppm; MALDI-TOF-
MS (pos) 22700. 
 
Acid-Catalyzed in Dichloromethane 3-(4-
Nitrophenyl)-3-(4-pyrolidin-1-yl-phenyl)-
propionaldehyde  
To a 5 mL amber scintillation vial equipped with 
a magnetic stir bar was added 4-
nitrocinnamaldehyde (13.7 mg, 0.077 mmol, 1.0 
equiv) dichloromethane (0.2 mL), and HCl (as a 
4N solution in 1,4-dioxane, 5 uL). The solution 
was cooled to -10°C in a salt/ice bath before 
addition of 1-phenylpyrrolidine (35.1 uL, 0.244 
mmol, 3.0 equiv). After 48 h, the crude reaction 
mixture was analyzed by NMR and product was 
found to be formed in a 4-
nitrocinnamaldehyde:product ratio of 1:1.2, 
providing evidence that any additional product 
formed after the 16 d mark in the on-dendrimer 
catalyst is due to catalytic activity, and not acid 
catalysis.   
 
Dendrimer-Bound Catalyst in 
Dichloromethane (S)-3-(4-Nitrophenyl)-3-(4-
pyrolidin-1-yl-phenyl)-propionaldehyde  
To a 5 mL amber scintillation vial equipped with 
a magnetic stir bar was added G(2.0) dendrimer-
bound (2S, 5S)-5-benzyl-2-tert-butyl-3-
methylimidazolidin-4-one (6.5 mg, 9.7E-4 
mmol, 0.20 equiv catalyst), dichloromethane (0.5 
mL), HCl to acidify the solution to pH ~4 (as a 
4N solution in 1,4-dioxane, 20 uL), and 4-
nitrocinnamaldehyde (14.5 mg, 0.082 mmol, 1.0 
equiv). The solution was cooled to -10°C in a 
salt/ice bath before addition of 1-
phenylpyrrolidine (34.3 uL, 0.234 mmol, 3.0 
equiv). After 16 d, the reaction mixture was 
transferred into dialysis tubing (MWCO 3500) 
and dialyzed against DCM. The DCM outside 
the dialysis tubing was concentrated in vacuo and 
subjected to silica gel chromatography via 
chromatotron. Gradient elution with 25-50% 
EtOAc in hexanes followed by concentration in 
vacuo afforded the product as a bright orange oil 
in 32.4% yield (8.6 mg, 0.027 mmol); []obs= -0.4  
 
 Dendrimer-Bound Catalyst in 
Dimethylsulfoxide (S)-3-(4-Nitrophenyl)-3-(4-
pyrolidin-1-yl-phenyl)-propionaldehyde  
 
To a 5 mL amber scintillation vial equipped with 
a magnetic stir bar was added G(3.0) dendrimer-
bound (2S, 5S)-5-benzyl-2-tert-butyl-3-
methylimidazolidin-4-one (14.0 mg, 1.0 E-3 
mmol, 0.20 equiv catalyst), dimethylsulfoxide 
(0.45 mL), HCl to acidify the solution to pH ~4 
(as a 4N solution in 1,4-dioxane, 30 uL), and 4-
nitrocinnamaldehyde (24.1 mg, 0.136 mmol, 1.0 
equiv). 1-phenylpyrrolidine was then added to 
the vial (57.3 uL, 0.398 mmol, 2.98 equiv). After 
20 d, the reaction mixture was transferred into 
dialysis tubing (MWCO 3500) and dialyzed 
against DMSO. The DMSO outside the dialysis 
tubing was concentrated under reduced pressure 
in a lyophilizer and subjected to silica gel 
chromatography via chromatotron. Gradient 
elution with 25-50% EtOAc in hexanes followed 
by concentration in vacuo afforded the product as 


a bright orange oil in 26.97% yield (11.9 mg, 
0.037 mmol); apparent []D= -1.89 (c=0.030 
mmol, 1 mL CHCl3), 45% ee. 
 
Free Catalyst in Acetonitrile and Water (2R)-
Bicyclo[2.2.2]oct-5-ene-2-carboxyaldehyde 
To a 5 mL amber scintillation vial equipped with 
a magnetic stir bar was added (2S, 5S)-5-benzyl-
2-tert-butyl-3-methylimidazolidin-4-one (24.2 
mg, 0.098 mmol), acetonitrile/water (95/5 v/v, 
0.13 mL), acrolein (500 uL, 7.48 mmol), and 
cyclohexadiene (240 uL, 2.52 mmol). The 
solution was stirred for 24 h, after which time the 
reaction mixture was diluted with diethyl ether 
(10 mL) and washed with water (10 mL). The 
aqueous layer was extracted with diethyl ether (5 
mL x 4) and the combined organics were dried 
(Na2SO4) and concentrated. Purification by silica 
gel chromatography (10% ether/pentane) 
afforded the title compound as a colorless oil in 
4% yield (14.0 mg, 0.10 mmol); apparent        
[]D= -535° (c=5.1*10E-6 mmol, 1 mL CHCl3) 
 
Dendrimer-Bound Catalyst in 
Dichloromethane (2R)-Bicyclo[2.2.2.]oct-5-
ene-2 carboxylaldehyde 
To a 5 mL amber scintillation vial equipped with 
a magnetic stir bar was added G(4.0) (2S, 5S)-5-
benzyl-2-tert-butyl-3-methylimidazolidin-4-one 
(3.0 mg, 1.07*E-4 mmol), dichloromethane,  
acrolein (6.5 uL, 0.097 mmol), and 
cyclohexadiene (5.0 uL, 0.052 mmol). The 
solution was stirred for 8 d, after which time the 
reaction mixture was diluted with diethyl ether 
(10 mL) and washed with water (10 mL). The 
aqueous layer was extracted with diethyl ether (5 
mL x 4) and the combined organics were dried 
(Na2SO4) and concentrated. Purification by silica 
gel chromatography (10% ether/pentane afforded 
the title compound as a colorless oil in 24% yield 
(17.4 mg, 1.3*10E-4 mmol); apparent                  
[]D = -460° (c=3.7*10E-2 mmol, 1 mL CHCl3) 
 
Free Catalyst in Dichloromethane (S)-3-(4-
Nitrophenyl)-3-(4-pyrolidin-1-yl-phenyl)-
propionaldehyde  
To a 5 mL amber scintillation vial equipped with 
a magnetic stir bar was added (2S, 5S)-5-benzyl-
2-tert-butyl-3-methylimidazolidin-4-one (24.1 
mg, 0.099 mmol, 0.20 equiv) dichloromethane 
(1.0 mL), HCl (as a 4N solution in 1,4-dioxane, 
25 uL), and 4-nitrocinnamaldehyde (88.5 mg, 
0.500 mmol, 1.0 equiv). The solution was cooled 
to -10°C in a salt/ice bath before addition of 1-
phenylpyrrolidine (216 uL, 1.485 mmol, 3.0 
equiv). After 48 h, the reaction mixture was 
subjected directly to silica gel chromatography. 
Gradient elution with 25-50% EtOAc in hexanes 
followed by concentration in vacuo afforded the 
product as a bright orange oil in 89% yield (162.1 
mg, 0.500 mmol); apparent []D=-2.77 (c=0.37 
mmol, 1 mL CHCl3), 67%ee. 
 
Free Catalyst in Dimethylsulfoxide (S)-3-(4-
Nitrophenyl)-3-(4-pyrolidin-1-yl-phenyl)-
propionaldehyde  
To a 5 mL amber scintillation vial equipped with 
a magnetic stir bar was added (2S, 5S)-5-benzyl-


2-tert-butyl-3-methylimidazolidin-4-one (27.6 
mg, 0.112mmol, 0.20 equiv) dimethylsulfoxide 
(0.5 mL), HCl (as a 4N solution in 1,4-dioxane, 
25 uL), and 4-nitrocinnamaldehyde (99.3mg, 
0.500 mmol, 1.0 equiv). The solution was cooled 
to -10°C in a salt/ice bath before addition of 1-
phenylpyrrolidine (241.8 uL, 1.68 mmol, 3.0 
equiv). After 48 h, the reaction mixture was 
subjected directly to silica gel chromatography. 
Gradient elution with 25-50% EtOAc in hexanes 
followed by concentration in vacuo afforded the 
product as a bright orange oil in 69.5% yield 
(126.4 mg, 0.390 mmol); apparent []D= -3.9 
(c=0.34 mmol, 1 mL CHCl3), 94%ee 
 
Free Catalyst in Dichloroethane (S)-3-(4-
Nitrophenyl)-3-(4-pyrolidin-1-yl-phenyl)-
propionaldehyde  
To a 5 mL amber scintillation vial equipped with 
a magnetic stir bar was added (2S, 5S)-5-benzyl-
2-tert-butyl-3-methylimidazolidin-4-one 
(25.6mg, 0.104mmol, 0.20 equiv) dichloroethane 
(1.0yk mL), HCl (as a 4N solution in 1,4-
dioxane, 30 uL), and 4-nitrocinnamaldehyde 
(92.2 mg, 0.512 mmol, 1.02 equiv). The solution 
was cooled to -10°C in a salt/ice bath before 
addition of 1-phenylpyrrolidine (223.0 uL, 1.55 
mmol, 3.0 equiv). After 48 h, the reaction 
mixture was subjected directly to silica gel 
chromatography. Gradient elution with 25-50% 
EtOAc in hexanes followed by concentration in 
vacuo afforded the product as a bright orange oil 
in 47.6% yield (80.3 mg, 0.248 mmol); []D=-
2.36 (c=0.13 mmol, 1 mL CHCl3), 57%ee 
 Characterization Notes 
1H NMR and 13C NMR for all functionalized 
dendrimer characterization was carried out in 
deuterated methanol. 13C NMR was optimized 
by running 8,000-9,000 scans on samples with a 
3 second relaxation delay.  
 
Optimum MALDI-TOF-MS characterization 
can be carried out in both trans-3-indolacrylic 
acid (IAA) or 2,5-dihydroxybenzoic acid (DHB) 
with dimethylformamide (DMF) as a solvent 
with the concentrations used in Table 4. It was 
found that DHB provided more consistent 
success in MALDI-TOF-MS analysis attempts. 
Myoglobin was used as a standard for calibration 
purposes. 
 
Myoglobin standards were prepared by adding 10 
uL of  myoglobin solution (1.6mg/mL H2O) to 
10 uL of DHB solution (20 mg/mL DHB in 80% 
ACN/H2O).  
 
Table 4: Optimal Concentration Range for MALDI-
TOF-MS Analysis 
Desired 
Concentration 
(Dendrimer:Matrix) 
uL 1mM 
Dendrimer 
Solution 
uL 1M 
Matrix 
Solution 
uL 0.1M 
Matrix 
Solution 
1:250 4 - 10 
1:500 2 - 10 
1:1000 1 - 10 
1:2500 4 10 - 
1:5000 2 10 - 
1:10k 1 10 - 
1:20k 1 20 - 
1:30k 1 30 - 


1M DHB Matrix solution was prepared by 
adding 0.0231g of DHB to 150 uL of DMF. 
 
0.1M DHB Matrix solution was prepared by 
adding 20 uL of 1M DHB solution to 180 uL of 
DMF.  
1 mM dendrimer solutions were prepared 
according to their theoretical mass based on 
functionalization and generation (Table 5).  
  
Table 5: Preparation of 1 mM dendrimer solutions. 
Generation Concentration  Dendrimer 
8  in DMF 
Concentration 
Dendrimers 4,5,6 in DMF 
G (2.0) 5.5mg/mL 6.7 mg/mL 
G (3.0) 12 mg/mL 14 mg/mL 
G (4.0) 24 mg/mL 28 mg/mL 
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